ImmunityBio Inc. Common Stock vs Cheniere Energy — how do they compare? ImmunityBio Inc. Common Stock trades at $10.01 (market cap $10.33B), while Cheniere Energy trades at $278.5 (market cap $56.22B). The key difference: Cheniere Energy is far larger — about 5.4× ImmunityBio Inc. Common Stock's market cap, and Cheniere Energy pays a 0.82% dividend while ImmunityBio Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold ImmunityBio Inc. Common Stock for 0 Days and Cheniere Energy for 10 Days on average.
| IBRX | LNG | |
|---|---|---|
Market Cap | $10.33B | $56.22B |
Volume | 11,745,198 | 1,191,547 |
Sector | Health | Energy |
52-Week High | $11.55 | $296.91 |
52-Week Low | $1.98 | $188.83 |
Typical Hold Time | 0 Days | 10 Days |
Enterprise Value | $10.79B | $81.68B |
Dividend Yield | — | 0.82% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
ImmunityBio develops immune-based therapies for cancer and infectious diseases. Its programs are designed to activate and strengthen the body’s immune response.
Read more on IBRX →Cheniere Energy produces, liquefies, and exports natural gas as liquefied natural gas, or LNG. It operates large-scale LNG infrastructure along the U.S. Gulf Coast.
Read more on LNG →